Immunotherapy

Aims & Scope

The field of immunotherapy is moving forward at an unprecedented rate, and a range of therapeutic approaches are now used in clinical practice, often with outstanding success.

Cancer immunotherapies are coming of age and have the potential to produce long-lasting remission, often with fewer side effects and reduced drug resistance compared with conventional therapies.

Recently the FDA has approved immunotherapies for melanoma and lung cancer, and clinical trials are yielding positive results for a range of cancer types, reflecting the promising new role for immunotherapy in cancer treatment.

Immunotherapies are also being applied in a variety of other disease areas, including allergy, rheumatoid disease, autoimmunity and transplantation, as well as in many infections, such as HIV and hepatitis.

Many aspects of the immune system and mechanisms of immunomodulatory therapies remain to be elucidated in order to exploit fully the emerging opportunities.

Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field.

The journal Immunotherapy offers the scientific community an interdisciplinary forum, providing them with information on the most recent advances of various aspects of immunotherapies, in a concise format to aid navigation of this complex field.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.3
2024	2.70

Journal Rank

Year	Value
2024	6368

Journal Citation Indicator

Year	Value
2024	1048

SJR (SCImago Journal Rank)

Year	Value
2024	0.835

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	69

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm

  Citation: 538

  Authors: Toshio, Masashi, Tadamitsu

• Tumor-Associated Macrophages: Implications in Cancer Immunotherapy

  Citation: 296

  Authors: Amy J, Yiping

• Toll-Like Receptor Agonists in Cancer Therapy

  Citation: 254

  Authors: Sylvia

• Gold Nanoparticles-Mediated Photothermal Therapy and Immunotherapy

  Citation: 209

  Authors: Yang, Bridget M, Tuan

• Anti-TNF-α Agents in the Treatment of Immune-Mediated Inflammatory Diseases: Mechanisms of Action and Pitfalls

  Citation: 186

  Authors: Léia CR, Luciena CM, Gil

• Controversies About COVID-19 and Anticancer Treatment with Immune Checkpoint Inhibitors

  Citation: 171

  Authors: Melissa

• Therapeutic Anti-Cd3 Monoclonal Antibodies: From Bench to Bedside

  Citation: 163

  Authors: Chantal, Howard L

• PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small-Cell Lung Cancer: Updated Survival Data

  Citation: 162

  Authors: Pedro N, Ramon Andrade, Peter, Hakaru, Gilberto de

• Recent Progress in GM-CSF-Based Cancer Immunotherapy

  Citation: 158

  Authors: Wan-Lun, Kuan-Yin, Chun-Yuan, Yu-An, Shih-Jen

• Targeting B-Cell Maturation Antigen in Multiple Myeloma

  Citation: 155

  Authors: Yu-Tzu, Kenneth C

---